Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of repeated applications of tenofovir gel on mucosal mediators of immunity and intrinsic antimicrobial activity of cervicovaginal secretions in women at low risk for HIV-1 infection.

Trial Profile

Effect of repeated applications of tenofovir gel on mucosal mediators of immunity and intrinsic antimicrobial activity of cervicovaginal secretions in women at low risk for HIV-1 infection.

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Feb 2017

At a glance

  • Drugs Tenofovir (Primary)
  • Indications HIV infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 May 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 12 May 2010 Actual patient number (30) added as reported by ClinicalTrials.gov.
    • 12 May 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top